Artificial intelligence (AI)–powered pathologic response (PathR) assessment of resection specimens after neoadjuvant atezolizumab in patients with non-small cell lung cancer: Results from the LCMC3 study.
暂无分享，去创建一个
M. Kris | V. Rusch | I. Wistuba | W. Travis | D. Carbone | S. Dacic | J. Giltnane | J. Fujimoto | L. Sholl | Jay M. Lee | A. Nicholas | K. Schulze | Ann M. Johnson | J. Ritter | F. Khalil | S. Hilz | F. Kos | M. D’Apuzzo | J. Abel | Stephanie Hennek | A. Johnson